Kelden Sciences Retatrutide 20 mg vial on a white background

.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}

Retatrutide 20mg

Name: Retatrutide 20mg
Brand: Kelden Peptides Canada
Price: 140 CAD
Availability: InStock
Rating: 5 (1 reviews)

Rating is 5.0 out of five stars based on 1 review

Price

$140.00

Retatrutide 20mg is an investigational research peptide designed to interact with three metabolic receptor systems: GLP-1, GIP and glucagon receptors. It is also referenced in scientific literature by the development identifier LY3437943.

The compound has become an important subject of metabolic research because its triple-receptor profile allows researchers to study combined incretin and glucagon signaling within a single molecular system. Research areas commonly include receptor activation, metabolic signaling, glucose-regulatory pathways and energy-balance mechanisms.

The 20mg format provides a mid-range Retatrutide research option between our Retatrutide 10mg, Retatrutide 30mg and Retatrutide 40mg formats.

Researchers can review Kelden Peptides Canada’ batch testing and lab reports and use our peptide dosage calculator for laboratory concentration calculations. For research use only.

Quantity

Research & Product Details

Compound: Retatrutide Also known as: LY3437943 Form: Lyophilized research peptide Strength: 20mg Research category: GLP-1 / GIP / glucagon triple-receptor research peptide Research overview: Retatrutide is an investigational peptide designed to engage GLP-1, GIP and glucagon receptor pathways within one molecular system. This triple-receptor profile has made it a major subject of metabolic and incretin research. Laboratory studies commonly examine receptor activation, signaling interactions between incretin pathways, glucose-regulatory mechanisms and broader energy-balance biology. The 20mg format provides a mid-range quantity for projects comparing the same compound across multiple strengths while keeping the underlying research identity consistent. Documentation: Published laboratory records are listed separately where available. Batch-specific testing and batch numbers can be added to this section once verified.